Differential expression of heparin-binding EGF-like growth factor (HB-EGF) mRNA in normal human keratinocytes induced by a variety of natural and synthetic retinoids

Experimental Dermatology, Supplement

Volumn 12, Issue 2, 2003, Pages 28-34

  Yoshimura, Kotaro ^a   Uchida, Gentaro ^a   Okazaki, Mutsumi ^a   Kitano, Yukie ^a   Harii, Kiyonori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Heparin binding EGF like growth factor (HB EGF); Keratinocyte; Retinoid; Retinol; Tretinoin

Indexed keywords

3,5 DI TERT BUTYL 4' CHALCONECARBOXYLIC ACID; 4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [1 HYDROXY 3 OXO 3 (5,6,7,8 TETRAHYDRO 3 HYDROXY 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; ALITRETINOIN; ER 38925; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; ISOTRETINOIN; MESSENGER RNA; RETINAL; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ALPHA AGONIST; RETINOIC ACID RECEPTOR PANAGONIST; RETINOID DERIVATIVE; RETINOL; TAC 101; TAMIBAROTENE; UNCLASSIFIED DRUG;

CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; KERATINOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0346873939     PISSN: 14791250     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.12.s2.5.x     Document Type: Conference Paper

References (29)

1. Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986: 15: 836-859.
2. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996; 10: 1002-1013.
3. Tur E, Hohl D, Jetten A, Panizzon R, Frenk E. Modification of late epidermal differentiation in photoaged skin treated with topical retinoic acid cream. Dermatology 1995: 191: 124-128.
4. Gibson DF, Bikle DD, Harris J. All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes. J Cell Physiol 1998: 174: 1-8.
5. Stoll SW, Elder JT. Retinoid regulation of heparin-binding EGF-like growth factor gene expression in human keratinocytes and skin. Exp Dermatol 1998: 7: 391-397.
6. Stoll S, Garner W, Elder J. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 1997: 100: 1271-1281.
7. Xiao JH, Di Feng X W et al. Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J 1999; 18: 1539-1548.
8. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975: 111: 40-48.
9. Yoshimura K, Harii K, Aoyama T, Iga T. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg 2000; 105: 1097-1108.
10. Yoshimura K, Momosawa A, Watanabe A et al. Cosmetic color improvement of the nipple-aerola complex by optimal use of tretinoin and hydroquinone. Dermatol Surg 2002; 28: 1153-1157.
11. Yoshimura K, Tsukamoto K, Okazaki M et al. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J Dermatol Sci 2001: 27: S68-S75.
12. Tsunenaga M, Kohno Y, Horii I et al. Growth and differentiation properties of normal and transformed keratinocytes in organotypic culture. Jpn J Cancer Res 1994: 85: 238-244.
13. Hashimoto Y, Kagechika H, Kawachi E, Shudo K. Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: Possibly the true retinoid receptor. Jpn J Cancer Res 1988: 79: 473-483.
14. Kagechika H, Kawachi E, Hashimoto Y, Himi T, Shudo K. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J Med Chem 1988: 31: 2182-2192.
15. Murakami K, Wierzba K, Sano M et al. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span. Clin Exp Metastasis 1998; 16: 323-331.
16. Yoshimura H, Kikuchi K, Hibi S et al. Discovery of novel and potent retinoic acid receptor alpha agonists: Syntheses and evaluation of benzofuranyl-pyrrole and benzothiophenyl-pyrrole derivatives. J Med Chem 2000: 43: 2929-2937.
17. Kagechika H, Kawachi E, Hashimoto Y, Shudo K. Retinobenzoic acids. 2. Structure-activity relationships of chalcone-4-carboxylic acids and flavone-4′-carboxylic acids. J Med Chem 1989: 32: 834-840.
18. Fisher GJ, Talwar HS, Xiao JH et al. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 1994: 269: 20629-20635.
19. Xu XC, Lotan R. Aberrant expression and function of retinoid receptors in cancer. In: Nau, H, Blaner, WS, eds. Retinoids. Berlin: Springer, 1999: 335-336.
20. Schule R, Rangarajan P, Yang N et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 1991: 88: 6092-6096.
21. Kang JX, Li Y, Leaf A. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc Natl Acad Sci USA 1997: 94: 13671-13676.
22. Siegenthaler G, Saurat JH, Ponec M. Retinol and retinal metabolism. Relationship to the state of differentiation of cultured human keratinocytes. Biochem J 1990: 268: 371-378.
23. Crettaz M, Baron A, Siegenthaler G, Hunziker W. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochem J 1990: 272: 391-397.
24. Saurat JH, Sorg O, Didierjean L. New concepts for delivery of topical retinoid activity to human skin. In: Nau, H, Blaner, WS, eds. Retinoids. Berlin: Springer, 1999: 521-538.
25. Soprano D, Blaner WS. Plasma retinol-binding protein. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids. Biology, Chemistry, and Medicine. 2nd ed. New York: Raven, 1994: 257.
26. Randolph RK, Siegenthaler G. Vitamin A homeostasis in human epidermis. Native retinoid composition and metabolism. In: Nau, H, Blaner, WS, eds. Retinoids. Berlin: Springer, 1999: 499-500.
27. DeLeenHeer AP, Lamber WE, Claeys I. All-trans retinoic acid: Measurement of reference values I human serum by high performance liquid chromatography. J Lipid Res 1982: 23: 1362-1367.
28. Eckhoff C, Nau H. Identification and quantitation of all-trans- and 13-cis retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J Lipid Res 1990: 31: 1445-1454.
29. Yoshimura K, Momosawa A, Watanabe A et al. Clinical trial of bleaching treatment with 10% all-trans retinol gel. Dermatol Surg 2003: 29: 155-160.